Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.768456
Title: Essays on entry and market profitability in the UK pharmaceuticals
Author: Yan, Weijie
ISNI:       0000 0004 7654 2332
Awarding Body: University of East Anglia
Current Institution: University of East Anglia
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
This thesis applies economic methods developed in industrial organization to assess entry barriers and profitability of the pharmaceutical market in the UK. The thesis has two parts. The first part investigates whether incumbent firms strategically proliferate product varieties to delay and deter entry of competitors, and whether such strategy is effective to be a barrier. Three sets of regressions are employed: a non-monotonicity test between number of products and market size, as proposed by Ellison and Ellison (2011); a hazard rate model of entry probability, with focus on whether entry can be influenced by product varieties; and a regression of incumbent's market share post entry to test whether their share is positively correlated with product varieties built prior to entry. The results suggest that product proliferation can be a barrier to entry in the UK, however, evidence on incumbents' strategic incentive is inconclusive. The second part of the thesis focuses on antibiotic market. With the use of antibiotics, bacteria start to develop resistance, which has became a global crisis in healthcare. Despite the need for new entries because old molecules are losing effectiveness, research firms are leaving this market. We use nested logit and random coefficients logit model to estimate the price elasticity of demand between drugs in order to assess the profitability of the market and to evaluate policy interventions of shifting consumption away from molecules that cause higher resistance. We find that price-cost margin of this market is 35.2% on average but varies by molecules and drug types (branded/generics). We also find that some interventions can be effective to shift demand but with prices to pay.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.768456  DOI: Not available
Share: